News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
KARSEN PERRY A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Converted 8,126 shares
@ $0
Granted 74,794 options to buy
@ $0
Granted 19,763 preferred shares
@ $5.06, valued at
$100k
Granted 18,698 options to buy
@ $0
Converted 19,763 preferred shares
@ $0 |
|
| 06/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/22/2021 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 15,700 options to buy
@ $7.27, valued at
$114.1k
|
|
| 12/18/2020 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 21,978 shares
@ $52.52, valued at
$1.2M
Sold 45,450 shares
@ $53.69, valued at
$2.4M
Sold 21,336 shares
@ $54.33, valued at
$1.2M
Exercised 31,764 options to buy
@ $18, valued at
$571.8k
Exercised 19,000 options to buy
@ $14.35, valued at
$272.7k
Exercised 19,000 options to buy
@ $25.98, valued at
$493.6k
Exercised 19,000 options to buy
@ $15.78, valued at
$299.8k
|
|
| 11/18/2020 |
3
| KARSEN PERRY A (Director) has filed a Form 3 on Jiya Acquisition Corp. |
| 07/02/2020 |
4/A
| KARSEN PERRY A (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 15,700 options to buy
@ $7.58, valued at
$119k
|
|
| 06/29/2020 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 13,550 options to buy
@ $7.58, valued at
$102.7k
|
|
| 06/19/2020 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 19,000 options to buy
@ $20.72, valued at
$393.7k
|
|
| 06/17/2019 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $24.68, valued at
$370.2k
|
|
| 06/13/2019 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 15,700 options to buy
@ $4.46, valued at
$70k
|
|
| 05/22/2019 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 19,000 options to buy
@ $15.78, valued at
$299.8k
|
|
| 04/23/2019 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Unknown transaction of 80,500 shares
@ $0 |
|
| 06/25/2018 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $2.55, valued at
$38.3k
|
|
| 06/21/2018 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 13,550 options to buy
@ $7.92, valued at
$107.3k
|
|
| 06/18/2018 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $21.64, valued at
$324.6k
|
|
| 05/21/2018 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 19,000 options to buy
@ $25.98, valued at
$493.6k
|
|
| 02/28/2018 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 70,500 shares
@ $0
Granted 120,000 options to buy
@ $2.29, valued at
$274.8k
|
|
| 06/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/05/2017 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $11.985, valued at
$59.9k
|
|
| 06/02/2017 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $3.3, valued at
$49.5k
|
|
| 05/19/2017 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 19,000 options to buy
@ $14.35, valued at
$272.7k
|
|
| 02/02/2017 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on Jounce Therapeutics, Inc. |
| 01/26/2017 |
3
| KARSEN PERRY A (Director) has filed a Form 3 on Jounce Therapeutics, Inc. |
| 06/24/2016 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $12.61, valued at
$189.2k
|
|
| 06/17/2016 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $13.7, valued at
$205.5k
|
|
| 05/09/2016 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 31,764 options to buy
@ $18, valued at
$571.8k
|
|
| 05/05/2016 |
3
| KARSEN PERRY A (Director) has filed a Form 3 on Intellia Therapeutics, Inc. |
| 01/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/18/2015 |
4
| KARSEN PERRY A (see remarks) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Paid exercise price by delivering 3,888 shares
@ $112.17, valued at
$436.1k
Exercised 7,500 restricted stock units
@ $0 |
|
|
|
|